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Maggot debridement therapy (MDT) consists on the intentional and con-
trolled application of sterilized larvae of the order Diptera on necrotic skin
lesions with the purpose of cleaning necrotic tissue and removing patho-
genic bacteria. During MDT, a marked antimicrobial activity has been re-
ported in literature specially associated with antibacterial substances from
Lucilia sericata (Meigen); however, regarding Cochliomyia macellaria
(Fabricius), little is known. This study aimed to evaluate in vitro inhibition
of bacterial growth of Pseudomonas aeruginosa and Staphylococcus
aureus in contact with excretions and secretions (ES) from C. macellaria
larvae. Larval ES were extracted in sterile distilled water and divided in
three groups: ES, containing 400 μL of autoclaved ES; ES+BAC, containing
400 μL of autoclaved ES+0.5-μL bacterial inoculum; and CONT-BAC, con-
taining 400 μL of sterile distilled water +0.5 μL of bacterial inoculum.
Aliquots of each experimental group were plated by spreading onto
Petri dishes. Seedings were made at 0, 1, 2, 4, and 12 h after the extraction
of ES. In ES+BAC groups, inhibition of S. aureuswas verified between times
1 and 2 h and P. aeruginosawas inhibited between 0 and 4 h. Therewas no
growth observed in any ES group. In the CONT-BAC groups, the number of
colonies from time 4 h became countless for S. aureus and decreased for
P. aeruginosa. As reported in the literature, we note here that ES have
excellent bactericidal activity for both gram-positive and gram-negative
bacteria, and this study shows for the first time the action of the bacteri-
cidal activity of exosecretions of C. macellaria against S. aureus and
P. aeruginosa.
Introduction
Maggot debridement therapy (MDT) or larval therapy (LT) is
an artificially induced therapeutic myiasis (Sherman 2009),
consisting on the application of live sterile larvae of flies
obtained in laboratory on chronic or infected wounds, aiming
to accelerate the healing process. High-cost treatments and
the emergence of multiresistant bacteria in chronic wounds
encouraged the resurgence of MDT, currently used in
approximately 20 countries and, more recently, in Brazil
(Nassu & Thyssen 2015).
Flies used for MDT belong mainly to Calliphoridae family
and are popularly known as blowflies. Despite having a rep-
utation of pests and carriers of parasites and pathogens
(Fleischmann et al 2004), larvae of some candidate species
have successfully been used as debriding agents in chronic
and infected wounds (Andersen et al 2010). Cochliomyia
macellaria (Fabricius) naturally inhabits organic matter such
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as feces, decaying carcasses, and necrotic tissues of living
animals (Guimarães et al 1983), all of which contaminated
by an abundance of pathogenic microorganisms. Thus, it is
not surprising that larvae have developed a number of effec-
tive mechanisms to eradicate, minimize, and/or control
these pathogens (Fleischmann et al 2004).
The promotion of wound healing by larvae can be divided
into three main areas: debridement (Chambers et al 2003),
disinfection/antibacterial activity (Erdmann & Khalil 1986),
and stimulation of formation of granulation tissue (Prete
1997; Chambers et al 2003). Bacterial reduction and disinfec-
tion of wounds by larvae were first observed by Dr. William
Baer, an orthopedic surgeon (Baer 1931). Bactericidal poten-
tial can be associated with properties of intestinal secretions
and excretions (also known as exosecretions or ES) of imma-
ture (Simmons 1935, Pavillard & Wright 1957).
Some researchers have suggested that the antibacterial
action is a result of the ingestion of microbes by larvae and
their intestinal activity (Robinson &Norwood 1934, Greenberg
1968). Recent studies using fluorescent microscopymonitored
the death of Escherichia coli during larval digestion, showing
reduced bacterial load in the intestine of Lucilia sericata
(Meigen) (Mumcuoglu et al 2001). Other groups have focused
on antimicrobial activity in larval secretions. The secretions of
L. sericata have exhibited antimicrobial activity against gram-
positive cultures of Streptococcus sp. and Staphylococcus
aureus (Thomas et al 1999). Furthermore, Proteus mirabilis,
a commensal of the larvae gut, showed activity against gram-
positive and gram-negative bacteria (Erdmann et al 1984,
Erdmann & Khalil 1986).
Several publications regarding antibacterial substances,
such as digestive enzymes and peptides originated from im-
mune system of larvae of L. sericata can be found in litera-
ture (Mumcuoglu et al 2001, Chambers et al 2003, Bexfield
et al 2004, Kerridge et al 2005, Bexfield et al 2009, Cazander
et al 2009, Kawabata et al 2010, Kruglikova & Chemysh 2011);
however, little is known about the antibacterials from
C. macellaria.
Given the failure of antimicrobials and the ability of bac-
teria to proliferate through biofilm (Bjarnsholt et al 2008),
the bactericidal potential of larvae is of great importance in
chronic wound healing process. Pseudomonas aeruginosa
and S. aureus are bacteria commonly found on wounds and
have antibiotic resistance reported. Hospital strains of
S. aureus are often resistant to many antibiotics (Okuma
et al 2002). Similarly, strains of P. aeruginosa are becoming
more frequently resistant to high concentrations of salt, col-
orings, antiseptics, and antimicrobials commonly used in clin-
ical medicine, being identified as amajor cause of nosocomial
infections (Brooks et al 2000). Bacteria within chronic
wounds often reside in biofilms, which protect bacteria
against the action of antibiotics (Stoodley et al 2002,
Cazander et al 2010, Harris et al 2013). Previous reports
showed that the sterile maggot ES could be effective against
biofilms of P. aeruginosa (Van der Plas et al 2008, Brown
et al 2012, Jiang et al 2012).
Thus, this study aimed to evaluate in vitro inhibition of
P. aeruginosa and S. aureus growth through excretion/
secretion (ES) of C. macellaria larvae, whose potential use
for MDT in Brazil has been evidenced recently by Masiero
et al (2015), Nassu & Thyssen (2015), and Masiero & Thyssen
(2016).
Material and Methods
Establishment of C. macellaria in laboratory
Cochliomyia macellaria colonies were established from col-
lections in natural environment using appropriate traps
(Moretti et al 2009), containing raw beef liver as bait.
Collected specimens were screened and identified according
to Grella & Thyssen (2011).
Selected adults were kept under controlled conditions of
temperature (27 ± 1°C), photoperiod (12:12 h), and relative
humidity (70 ± 10 %). Stimulation of posture was performed
by placing a 50 g portion of raw ground beef inside the cage.
Extraction of larval excretions and secretions
Larvae were allowed to feed on raw ground beef for 72 h.
After this period, they were removed from the meat and
washed with 70% ethanol, then rinsed in sterile distilled wa-
ter. Excretions and secretions (ES) were obtained according
to Arora et al 2010. Larvae were divided in groups consisting
on 25 live larvae each, then transferred to 1-ml microtubes
with 800 μL of sterile distilled water each, being centrifuged
at 4000×g at 4°C for 15 min and then maintained at 37 ± 2°C
for 1 h in the dark. To ensure that there were no contami-
nants present in the external solution, larvae were removed
from the microtubes and discarded, and the remaining ex-
tracted ES was autoclaved at 1 atm, at 121°C for 20 min, then
refrigerated (15 ± 2°C) for 15 min.
The isolates of S. aureus and P. aeruginosa were provided
by the Laboratory of Bacteriology of UFPel and the
Laboratory of Microbiology of UNICAMP, respectively.
Bacterial suspensions were prepared in 0.5 Mac Farland
scale, and from this suspension, final dilutions of 10−4 for
S. aureus and 10−6 for P. aeruginosa were obtained.
The experiments were divided into three groups: (i) ES
group containing 400 μL of autoclaved larval excretions
and secretions, (ii) ES+BAC group containing 400 μL of
autoclaved larval excretions and secretions +0.5-μL bacterial
inoculum, and (iii) CONT-BAC group containing 400 μL of
sterile distilled water +0.5 μL of bacterial inoculum.
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Seeding and reading of the plates
Aliquots of 25 μL of each experimental group (ES, ES+BAC,
and CONT-BAC) were plated by spreading onto Petri dishes
containing BHI agar (Brain Heart Infusion) with two replicates
for each treatment. Seedings were made at 0, 1, 2, 4, and
12 h after the extraction of ES. Petri dishes were incubated at
37°C, according to the reading period set. The counting of
colony forming units (CFU/mL) was performed on a colony
counter. Plates presenting less than 30 and more than 300
CFUs were considered uncountable.
Results and Discussion
Pseudomonas aeruginosa
In the ES group, there was no growth of bacteria colony in
any of the observed readings. In ES+BAC group, the ES of
C. macellaria larvae showed bactericidal potential against
P. aeruginosa for up to 4 h (Fig. 1). Barnes et al (2010) also
observed the control of the growth of this bacteria for up to
4 h using ES of L. sericata. After 4 h, CFU number was un-
countable. In the CONT-BAC group (Fig. 1), the number of
CFUs declined after 4 h due to the lack of nutrients in the
medium, and also because gram-negative bacteria cell wall is
less resistant when compared to gram-positive bacteria cell
wall, in adverse environmental conditions (Brooks et al
2000). Jaklic et al (2008) established a prolonged lag phase
of 5–6 h for P. aeruginosa. These data contrast with data
reported in this study, in which lag phase was observed
between times 0-4 h.
Staphylococcus aureus
In the ES group, there was no growth of any colony of bac-
teria in any of the observed readings. In the ES+BAC group,
the bacterial growth of S. aureuswas uncountable at 0 h, and
its inhibition occurred in the range of 1–2 h (Fig. 2). At the
time 1 h, 172 CFUs were counted, while at the time 2 h, no
CFU was observed. In the CONT-BAC group, the number of
colonies became countless from the time 4 h, even inoculat-
ed into a medium with lack of nutrients, since gram-positive
bacteria are characterized by greater resistance to environ-
ment due to their cell wall being formed only by peptidogly-
can (Brooks et al 2000).
A short period (about 1 h) of growth inhibition of S. aureus
was observed. However, the fact that larval ES did not always
maintain an antibacterial effect during experimental period
does not minimize its potential to an antibacterial agent.
Several experiments conducted in our lab have demonstrat-
ed that larval ES are produced continuously. Therefore, even
short-lived antibacterial activity would still be an effective
defense against microbes in vivo (Barnes et al 2010).
Bexfield et al (2008) demonstrated that after 6 h,
L. sericata ES was able to reduce the population of
S. aureus, showing 91.5 % bactericidal potential. Jaklic et al
(2008) demonstrated the inhibition of bacterial growth be-
tween 0 and 4 h and 100 % reduction of S. aureus after 8 h.
Ratcliffe et al (2015) demonstrated that Chrysomya putoria
Fig. 1 Growth of Pseudomonas aeruginosa colonies in CONT-BACT (bacteria control), ES+BAC (larval exosecretions with bacteria) and ES (larval
exosecretions) experimental groups in seedings at times 0, 1, 2, 4, 6, and 12 h. *unc uncountable.
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(Wiedemann) and Chrysomya megacephala (Fabricius) ES
strongly inhibited S. aureus growth for up to 6 h. These dif-
ferences may be due to variation in the concentration of
larval ES, the types of medium used for cultivation and pos-
sibly the use of different fly species, since this is the first time
that ES of C. macellaria larvae was tested for the inhibition of
growth of pathogenic bacteria.
As reported in the literature, we note here that ES have
excellent bactericidal activity for both gram-positive and gram-
negative bacteria, despite differences between cell walls
(Bexfield et al 2004, Kerridge et al 2005). The resident micro-
flora of the digestory tract of larvae secretes antibacterial com-
ponents such as oligopeptides (Bexfield et al 2004) and disin-
fectants (Erdmann& Khalil 1986) that act lowering the pH of the
wound bed (Baer 1931). It is possible that this new condition
may have contributed to the inhibition/decrease of the growth
of P. aeruginosa and S. aureus, even for a short period. Thus,
we can infer that the bactericidal properties are related to the
larval exosecretions (Simmons 1935, Pavillard & Wright 1957).
Since multiple factors are responsible for the antibacterial activ-
ity of maggot excretions, it is evident that the efficiency of the
exosecretions, and hence of larval therapy, depends on the
microbiological and physico-chemical conditions present the
larvae immediate environment (Jaklic et al 2008).
Given the advantages of larval exosecretions, an association
of ES with antibiotics can indeed be a promising line for the
development of new treatments for biofilm-associated diseases
(Van der Plas et al 2008). Cazander et al (2009) observed that a
low concentration of gentamicin is already bactericidal in the
presence of maggot ES and could therefore confer better pa-
tient security by reducing the risks of severe gentamicin-related
side effects, such as nephrotoxicity and hearing loss. Arora et al
(2011) found out that L. sericata ES helped to enhance the
activity of ciprofloxacin at sub-MIC levels, in combination with
ciprofloxacin (at 80 and 60 % MIC concentrations).
This study shows for the first time the action of the bacte-
ricidal activity of exosecretions of C. macellaria against
S. aureus and P. aeruginosa. This finding is promising since it
represents an alternative for the treatment of infected and
chronic wounds and in treatments which classic MDT cannot
be used, i.e., the application of the larvae directly on the injury,
due to proximity of the large caliber vessels, organs, or when
there is formation of large cavities. It can also be a great alter-
native if the application of larvae directly on the wound is not
desired by the patient, as the extracted ES can be used to
complement usual treatments.
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